NASDAQ: CYAD       Celyad Sa Ads
Last Price Today's Change   Day's Range   Trading Volume
8.365   -0.225 (2.62%)  8.30 - 8.59  10,100


Avg Volume (4 weeks):14,147
4 Weeks Range:7.345 - 9.263
4 Weeks Price Volatility (%):
52 Weeks Range:4.10 - 13.01
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Celyad SA is a biopharmaceutical company, specialized in cell therapy. It develops technologies and treatments to treat severe diseases with poor prognosis. The company focuses on Immuno oncology, Cardiology, and Medical devices. Its main product candidates include CAR-T NKR-2, C-Cure. The firm has CYAD-01, CYAD-02, CYAD-03 programs in pipeline. The company owns trademarks and service marks including CELYAD, C-CATH, C_CURE, CATH and C-CATHez and CARDIO 3 BIOSCIENCES. The firm has Cardiology and Corporate operating segments. It derives majority of its revenues from Cardiology segment.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

3395  5701  443  114 

Top 10 Active Counters
 SNDL 0.714-0.029 
 BNGO 8.43+0.80 
 SENS 1.58-0.26 
 CCIV 18.36+0.55 
 CTRM 0.336-0.01 
 AMC 2.33+0.13 
 BB 9.84-0.84 
 OBSV 4.07+0.53 
 AVGR 1.47-0.37 
 ZOM 0.975-0.065